Significant Ownership of Andera Partners
- Signature - Title
- /s/ Stephane Bergez - By Stephane Bergez, Managing Partner
- Location
- Paris
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by Andera Partners.
Follow Filing Activity
Follow Andera Partners and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
Useful next steps after a schedule filing
Use the page below that answers the next obvious question about this reporting manager or security.
- Latest 13D/G reports to compare this manager with other current ownership disclosures.
- Latest insider ownership reports if you want insider activity alongside the beneficial ownership record.
- Latest 13F portfolio filings for broader institutional context.
- Latest investment quarter holder pages when the next step is security-level holder history.
Significant Ownership of Andera Partners
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| IVA | Inventiva S.A. | Ordinary Shares, nominal value Euro 0.01 per share | 7.7% | $80,593,658 | +$10,381,814 | 14,114,476 | +15% | Andera Partners | 31 Dec 2025 |
| EVOMMUNE, INC. | Common Stock, $0.0001 par value per share | 6% | 1,897,362 | Andera Partners | 07 Nov 2025 | ||||
| MLYS | MINERALYS THERAPEUTICS, INC. | Common Stock, $0.0001 par value per share | 4.2% | $39,747,075 | 2,765,976 | Andera Partners | 30 Jun 2025 |
Schedules 13D/G Reported by Andera Partners:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.